Sunil S Badve

40PUBLICATIONS
233CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisPredictive and prognostic markersMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (40)

|Aug 20, 2026
Pathologic Complete Response (pCR) Rate and Predictors of Response to Taxane, Trastuzumab, and Pertuzumab in HER2‑Positive Breast Cancer: Secondary Analyses of EA1181/CompassHER2 pCR.

|Jun 08, 2026
Integrated Molecular and Clinical Analysis of Thymic Epithelial Tumors.

|Mar 31, 2026
Computationally Derived Spatial Immune Signature Identifies Trastuzumab Responders in HER2+ Breast Cancer: NSABP B-41 Clinical Trial Validation.

Satvika Bharadwaj, Germán Corredor, Hilmi Al-Shakhshir

|Feb 11, 2026
HER2 testing in multiple solid tumor types: concordance of immunohistochemistry scores between three HER2 scoring algorithms.

Sunil S Badve, Michelle Shiller, Wentao Yang

|Jan 28, 2026
Non-Canonical Senescence Phenotype in Resistance to CDK4/6 Inhibitors in ER-Positive Breast Cancer.

Aynura Mammadova, Yuan Gu, Ling Ruan

|Nov 27, 2025
A Thymus-Independent Artificial Organoid System Supports Complete Thymopoiesis from Rhesus Macaque-Derived Hematopoietic Stem and Progenitor Cells.

Callie Wilde, Saleem Anwar, Yu-Tim Yau

Pageof 7

Frequent Collaborators

11 joint publications

Yesim Gökmen-Polar

6 joint publications

David L Rimm

5 joint publications

Sandra Demaria

5 joint publications

Sherene Loi